Sera from patients with proven cases of syphilis were tested for the presence of antibodies to structurally important phospholipids by using qualitative and quantitative assays. All 47 sera examined qualitatively contained antibodies to cardiolipin, phosphatidic acid, and phosphatidylserine, but not antibodies to other selected phospholipids. Such reactivity was not found in normal (Red Cross) sera. Although the degree of antibody binding to phospholipids varied in individual sera, reactivity was almost always greater with cardiolipin than with phosphatidic acid or phosphatidylserine. Binding saturability was found in sera as the cardiolipin concentration was increased over a constant area of nitrocellulose paper. Anti-cardiolipin binding measured by the protein A method gave results similar to the results measured by using anti-immunoglobulin G, which supports the conclusion that binding was to the F.b portion of the immuqoglobulin molecule. When measured as a function of serum concentration and plotted in double-reciprocal fasl#ion, the anti-cardiolipin binding data for two syphilitic sera had similar Kd values but different B,,. values. Stoichiometric calculations indicated that approximately 11,000 to 16,000 mol of cardiolipin appeared to be bound per mole of labeled second antibody. These observations may mean that the anti-cardiolipin antibody does not recognize the individual cardiolipin molecule as the antigenic site but recognizes some structural form of the phospholipid or that steric hindrance related to the interaction of the phospholipid with nitrocellulose paper prevented the bulk of cardiolipin molecules from reacting. The structural specificity of the antibodies identified excludes the possibility that these antibodies are directed against the phosphodiester linkage. These findings should give impetus to future study of a potential pathogenic or marker role for these antibodies in syphilis and in other syndromes in which membrane damage may be a primary event.
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Cardiolipin (CL) was discovered in 1942 (14) , and final identification of the structure of this compound was provided when diphosphatidylglycerol was synthesized and found to be identical to ox heart CL with respect to chromatographic behavior, melting point, optical rotation, and infrared absorption. The synthetic compound was also shown to substitute for CL in the serological tests for syphilis (2) .
Although still used for screening purposes, flocculation tests have been replaced by more specific tests for treponemal antigens to confirm diagnoses of syphilis. In connection with false-positive tests for syphilis, there has been recent interest in anti-CL antibodies, which have been observed with increasing frequency in patients with central nervous system manifestations of systemic lupus erythematosus (SLE) and other clinical situations in which vascular thrombosis occurs (4, 5, 18) . This new interest brings up the question of whether anti-CL antibodies in patients with syphilis are distinguishable from anti-CL antibodies in patients with other conditions. However, impeding investigations into this question is the fact that little is known about the reactivity of anti-CL antibodies in patients with syphilis at the molecular level, including the specificity of various portions of the phospholipid (PL) molecule, the physical form of the PL, the stoichiometry, whether the antibodies are directed against host or spirochetal CL, and whether the antibodies could play any pathogenic role, particularly against cell membranes.
In 0.1% Tween 20, pH 7.4) for 1 h at 25°C. The papers were then incubated for 16 h in blocking buffer containing serum (1:100) or as indicated below. The strips were then washed three times in blocking buffer for 10 min and were incubated with goat anti-human IgG-peroxidase conjugate diluted 1:1,000 in phosphate-buffered saline at room temperature for 90 min. The papers were washed three times with phosphatebuffered saline, and color development was visualized after the papers were placed in a solution containing 50 mg of diaminobenzidine per 100 mng of phosphate-buffered saline and 0.04% H202.
Quantitative anti-PL antibody identification. For experiments in which the serum (antibody) concentration was varied, nitrocellulose papers were cut into circles (diameter, 1 cm) and spotted with 65 nmol of PL. The circles and a blank were placed in 50-ml conical centrifuge tubes containing 4 ml of 3% gelatin blocking buffer and were incubated for 1 h in a 330 angle centrifuge rack. Syphilitic serum was added in amounts of 5, 10, 20, 30, 50, 70, and 100 [lI. For experiments in which the serum concentration was held constant, 3 to 136 nmol of CL was spotted onto the circles. After incubation for 60 min, normal or syphilitic serum diluted 1:50 in blocking buffer was added. The tubes were agitated for 16 h at 25°C in the angled racks. The papers were removed and washed three times for 15 '4C-labeled protein A was prepared as previously described (13) . Goat-derived affinity-purified anti-human IgG was prepared from 14C-labeled acetic anhydride in the same manner.
The specific activity of the labeled antibody protein was measured and used to convert the number of disintegrations per minute to the number of moles of second antibody.
For most experiments the amount of antibody binding was plotted after subtraction of the number of background counts (nitrocellulose without PLs) for each experimental point. The binding of the labeled second antibody or labeled protein A to the nitrocellulose paper and the binding to the paper with PL but without human serum were negligible.
RESULTS
The qualitative assay for bound antibody to PLs in which an enzyme-labeled assay (peroxidase) was used to rapidly compare the reactivities of many lipids with the same serum. In contrast to sera from normal subjects, which in this system showed little or no reactivity, all of the sera from patients with syphilis (n = 47) contained antibodies to CL, phosphatidic acid, and phosphatidylserine but not antibodies to phosphatidylcholine (egg phosphatidylcholine or phosphatidylcholine with synthetic short-chain fatty acids), phosphatidylethanolamine, or a free fatty acid (palmitic acid) (Fig. 1) . Therefore, CL, phosphatidic acid, and phosphatidylserine were used for quantitative measurements of antibody binding.
All of the binding study data below refer to individual sera from subjects with syphilis or normal subjects. No pooled sera were used. of the amount of CL placed on the nitrocellulose papers (constant volume and constant area). With two syphilitic sera saturation was reached, but with the normal sera there was only a slight increase above the nonspecific binding level which was represented by the amount of antibody found when no CL was present. There was a slight tendency for some of the binding curves to decrease at higher CL levels; the significance of this observation is not clear. Figure 3A shows the binding curves when another serum from a subject with syphilis was used. In this case the binding to CL was compared with the binding to phosphatidylserine and phosphatidic acid, which were placed in equimolar amounts on the nitrocellulose papers. The data were derived by using constant amounts of PLs, increasing amounts of serum, and a constant volume. The amount of binding was much less with phosphatidylserine and phosphatidic acid than with CL, with no clear tendency to plateau in any case. Figure 3B shows the results of an experiment in which we studied the binding curves for another serum from a syphilitic patient in relation to CL, phosphatidylserine, and phosphatidic acid. Again the binding to CL was greater and appeared to plateau, whereas with the other two PLs such a trend was not obvious.
The data for serum from another syphilis patient are shown in Fig. 3C . In this case, the binding to CL was indistinguishable from the binding to phosphatidylserine, and the binding to both of these compounds was considerably greater than the binding to phosphatidic acid. This situation was quite unusual in our experience, but does illustrate a variation that could be significant. This finding could not be pursued because additional samples of sera from the same individuals were unobtainable. In most cases the CL binding far exceeded the binding to any other PL studied.
To further examine anti-CL reactivity, the levels of binding of two different syphilitic sera were studied by using two different compounds to measure binding, namely "'C-labeled IgG and "'C-labeled protein A. As Fig. 4 shows, peak binding levels varied from case to case, but there were consistent points of binding saturation around 60 nmol of added CL, with no substantial change thereafter. It is also apparent that the level of binding measured by using anti-IgG was greater. However, the plateau levels which were reached by each method differed by a factor of two or less. Figure 5 shows the anti-CL binding curves for two additional sera from patients with syphilis. When antibody binding was plotted as a function of increasing serum concentration, the typical hyperbolic binding curve was evident. When the binding data were then linearized by using a double-reciprocal plot (Fig. 5, inset) , the intercepts on the abscissa (apparent Kd) were about the same. However, the ordinate intercepts differed, indicating that there were differences in the Bmax (reciprocal of moles of IgG bound per mole of antigen at saturation). Calculation of the apparent stoichiometry based on these intercepts gave values of approximately 11,000 to 16,000 mol of CL bound per mol of labeled anti-IgG antibody. DISCUSSION All 47 sera from patients with syphilis studied had demonstrable antibodies to CL in a system with no other lipids present. The majority also demonstrated antibody binding to In contrast to our results with IgG antibody, these workers nti-CL binding in sera from two syphilitic subjects as a also found IgM antibody activity toward phosphatidylncreasing serum concentrations. CL (65 nmol) was ethanolamine, but binding to phosphatidylserine was miniiitrocellulose papers. The inset shows a doublemal in the few sera which were tested.
)t derived from the same data.
Although their pathogenic role remains unestablished, human antibodies to PLs (especially to CL) have been described in association with a variety of other diseases in c acid and to phosphatidylserine to lesser ex-which membrane damage may be a predominant event, eactivity was found to egg or short-chain synincluding multiple sclerosis (3) and autoimmune thrombocy3hatidylcholine, phosphatidylethanolamine, chotopenic purpura (6) . Special attention has recently been fatty acids. We also found (data not shown) very directed toward a subset of patients with SLE who as a dy activity toward phosphatidylglycerol. These group demonstrate an association between the presence of cate that there was a high degree of structural anti-CL antibodies (measured by radioimmunoassay) and or the anti-CL and other PL antibodies which the binding of the lupus anticoagulant, thrombocytopenia, in the syphilitic sera which we studied. Antibodand venous and arterial thrombotic events (4, 5, 18) . There is against CL have been classically studied in conflicting evidence regarding the specificity of anti-CL l complex system which also contains phospha-activity in SLE sera, especially concerning the crossand cholesterol (8) . We concluded that CL is a reactivity of CL (and possibly other PL) antibodies with requires the presence of phosphatidylcholine for native and denatured DNAs (7, (9) (10) (11) . In SLE a case has ty. However, the enhancement of CL antigenicbeen made for a common reactive antigenic site located in ihatidylcholine and cholesterol may be subject to the phosphate diester linkage area which is common to the factors other than those which modify antigennucleic acid and PL molecular structures (9, 16 The results of the studies described above indicate that PL ibodies in normal sera, as well as higher levels of antibodies with specific reactivity patterns exist in syphilitic binding (paper without PLs). This difference sera. The question of the disease specificity of these and bly resulted from selective factors based on similar antibodies will require further study. Some evidence that such specificity may exist has been reported by the stoichiometry between goat anti-IgG and Shoenfeld et al. (17) , who found discordancy in terms of the bound on nitrocellulose paper is not definitely frequency of an anti-CL-related antibody (the lupus antiknown that the protein A stoichiometry is 2 to 1 coagulant) in syphilitic sera on the one hand and in sera from sults with the same sera (Fig. 4) 
